HaemaLogiX raises $10 million to advance multiple myeloma treatments
- Written by PR Newswire
- HaemaLogiX completes a fully subscribed $10 million share placement and welcomes Platinum Asset Management as core new institutional investor within its Platinum International Health Care Fund
- Funding underpins HaemaLogiX's drug development pipeline, targeting multiple myeloma - the second most common haematological cancer worldwide
- Lead drug,...
